NO741365L - Analogifremgangsmåte til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater. - Google Patents

Analogifremgangsmåte til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater.

Info

Publication number
NO741365L
NO741365L NO741365A NO741365A NO741365L NO 741365 L NO741365 L NO 741365L NO 741365 A NO741365 A NO 741365A NO 741365 A NO741365 A NO 741365A NO 741365 L NO741365 L NO 741365L
Authority
NO
Norway
Prior art keywords
derivatives
preparation
therapeutically active
analogous process
substituted pyrazolone
Prior art date
Application number
NO741365A
Other languages
English (en)
Other versions
NO138530B (no
NO138530C (no
Inventor
Egbert Wehinger
Eike Möller
Harald Horstmann
Karl Meng
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2319280A external-priority patent/DE2319280A1/de
Priority claimed from DE2363139A external-priority patent/DE2363139A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO741365L publication Critical patent/NO741365L/no
Publication of NO138530B publication Critical patent/NO138530B/no
Publication of NO138530C publication Critical patent/NO138530C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO741365A 1973-04-17 1974-04-16 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater NO138530C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2319280A DE2319280A1 (de) 1973-04-17 1973-04-17 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363139A DE2363139A1 (de) 1973-12-19 1973-12-19 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO741365L true NO741365L (no) 1974-10-18
NO138530B NO138530B (no) 1978-05-12
NO138530C NO138530C (no) 1978-09-20

Family

ID=25764996

Family Applications (1)

Application Number Title Priority Date Filing Date
NO741365A NO138530C (no) 1973-04-17 1974-04-16 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater

Country Status (27)

Country Link
US (1) US3957814A (no)
JP (1) JPS5314071B2 (no)
AR (5) AR207444A1 (no)
AT (1) AT337176B (no)
BG (5) BG21405A3 (no)
CA (1) CA1034953A (no)
CH (5) CH596172A5 (no)
DD (1) DD113757A5 (no)
DK (1) DK136066C (no)
EG (1) EG11157A (no)
ES (3) ES425373A1 (no)
FI (1) FI57587C (no)
FR (1) FR2226172B1 (no)
GB (1) GB1429141A (no)
HK (1) HK70276A (no)
HU (1) HU168590B (no)
IE (1) IE39212B1 (no)
IL (1) IL44626A (no)
LU (1) LU69872A1 (no)
NL (1) NL177917C (no)
NO (1) NO138530C (no)
PH (1) PH14829A (no)
PL (1) PL96883B1 (no)
RO (2) RO69740A (no)
SE (1) SE408301B (no)
SU (2) SU541430A3 (no)
YU (1) YU104874A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056533A (en) * 1973-04-17 1977-11-01 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2526467A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3306366A1 (de) * 1983-02-24 1984-08-30 Bayer Ag, 5090 Leverkusen Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 2―ピラゾリン―5―オン類の製造法
DE3738963A1 (de) * 1987-11-17 1989-05-24 Bayer Ag 3-aminopyrazolin-5-one
GB8912861D0 (en) * 1989-06-05 1989-07-26 Sherritt Gordon Ltd Purification of elemental sulphur
US5711929A (en) * 1989-05-06 1998-01-27 698638 Alberta Ltd. Purification of elemental sulphur
JPH079410Y2 (ja) * 1989-05-08 1995-03-06 株式会社アンレット 炭酸ガスレーザー光線発振器用ルーツブロワー
US5399565A (en) * 1990-07-17 1995-03-21 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
US5300514A (en) * 1990-07-17 1994-04-05 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
ES2131506T3 (es) * 1990-09-21 1999-08-01 Rohm & Haas Dihidropiridacinonas y piridacinonas como fungicidas.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
NL121416C (no) * 1961-05-31

Also Published As

Publication number Publication date
CH605797A5 (no) 1978-10-13
CH596172A5 (no) 1978-02-28
IL44626A (en) 1980-01-31
PH14829A (en) 1981-12-16
DD113757A5 (no) 1975-06-20
EG11157A (en) 1978-03-29
YU104874A (en) 1982-02-28
AR205272A1 (es) 1976-04-21
DK136066B (da) 1977-08-08
HU168590B (no) 1976-06-28
PL96883B1 (pl) 1978-01-31
BG22821A3 (no) 1977-04-20
NL177917C (nl) 1985-12-16
BG21217A3 (no) 1976-03-20
NL177917B (nl) 1985-07-16
NO138530B (no) 1978-05-12
BG21857A3 (no) 1976-09-20
IL44626A0 (en) 1974-06-30
IE39212L (en) 1974-10-17
ES447064A1 (es) 1977-09-16
BG21218A3 (no) 1976-03-20
ES425373A1 (es) 1976-09-01
ES447063A1 (es) 1977-06-16
FR2226172B1 (no) 1978-07-28
DK136066C (da) 1978-01-16
AR204951A1 (es) 1976-03-19
SU539525A3 (ru) 1976-12-15
FR2226172A1 (no) 1974-11-15
BG21405A3 (no) 1976-05-20
IE39212B1 (en) 1978-08-30
CH605801A5 (no) 1978-10-13
AR205271A1 (es) 1976-04-21
FI57587C (fi) 1980-09-10
HK70276A (en) 1976-11-19
AT337176B (de) 1977-06-10
RO63749A (fr) 1979-01-15
LU69872A1 (no) 1974-11-28
SU541430A3 (ru) 1976-12-30
AR208192A1 (es) 1976-12-09
AR207444A1 (es) 1976-10-08
FI57587B (fi) 1980-05-30
NL7405115A (no) 1974-10-21
SE408301B (sv) 1979-06-05
NO138530C (no) 1978-09-20
US3957814A (en) 1976-05-18
GB1429141A (en) 1976-03-24
CA1034953A (en) 1978-07-18
CH605800A5 (no) 1978-10-13
CH603592A5 (no) 1978-08-31
JPS5314071B2 (no) 1978-05-15
RO69740A (ro) 1982-09-09
AU6817474A (en) 1975-10-23
ATA313274A (de) 1976-10-15
JPS5018466A (no) 1975-02-26

Similar Documents

Publication Publication Date Title
NO740272L (no) Analogifremgangsmåte til fremstilling av 3-substituerte 4-fenylpiperidiner.
NO740137L (no) Analogifremgangsmåte ved fremstilling av terapeutisk virksomme karboksylsyrederivater.
NO741815L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive etylenderivater.
NO741084L (no) Fremgangsmåte til fremstilling av orale legemiddelpreparater.
NO740516L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive indolderivater.
NO741227L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive penicillinderivater.
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO740543L (no) Analogifremgangsmåte ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater.
NO741365L (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater.
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO740675L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme dotriacontapeptidamider.
NO741364L (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser.
NO740405L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater.
NO740327L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner.
NL185564C (nl) Werkwijze ter bereiding van pyrazoolderivaten.
NO740184L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 2-(fenoksyalkyltio)imidazolforbindelser.
NO740614L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser.
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
DK129350B (da) Fremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinonderivater.
NO741350L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive benzylaminer.
NO740841L (no) Fremgangsmåte for fremstilling av 1-beta-D-ribofuranosyl-1, 2, 4-triazol-3-karboksamid.
NO741752L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner.
NO740779L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 6-substituerte 3-karbetoksyhydrazinopyridaziner.
NO741044L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triaziner.